… This study was undertaken to design, formulate and evaluate timolol maleate and
brimonidine tartrate for stimuli-sensitive hydrogels. The formulations were evaluated for various …

… The objective of this study was to assess the hypotensive efficacy of timolol maleate 0.5%,
brinzolamide 1%, or brimonidine tartrate 0.2% ophthalmic solution, administered in …

… Brimonidine tartrate and Timolol Maleate are used in treatment of glaucoma by decreasing …
(lambda=254.0 nm for Brimonidine Tartrate and 300.0 nm for Timolol Maleate). The proposed …

… hypertension were randomized to receive bilaterally fixed combination of brimonidine/timolol
maleate 0.5% or fixed combination of dorzolamide 2%/timolol 0.5% twice daily at 8:00 AM …

… In the present study ocular inserts of brimonidine tartrate and timolol maleate prepared from
natural bioadhesive polymer, sodium alginate exhibited good control in the release of the …

… of timolol maleate and brimonidine tartrate for the treatment of glaucoma. Niosomal formulations
of brimonidine tartrate and timolol maleate … of timolol maleate and brimonidine tartrate in …

… At the baseline visit, patients were randomly assigned to receive masked study medication
(either brimonidine tartrate 0.2% or timolol maleate 0.5% sterile ophthalmic solution) and …

… brimonidine tartrate 0.1% ophthalmic solution (brimonidine) and timolol maleate 0.5%
ophthalmic solution (timolol) in … of brimonidine in terms of intraocular pressure (IOP) reduction. …

… to 35 µg/ml of Brimonidine tartrate and timolol maleate at 247.0 nm … determination of
Brimonidine tartrate and timolol maleate in ophthalmic formulation. … The combination of …

… The purpose of this study was to evaluate the safety and efficacy of a fixed combination of
timolol maleate 0.5% + brimonidine tartrate 0.2% (Combigan®) for reduction for intraocular …